www.fdanews.com/articles/97028-unigene-in-licenses-potential-therapies-for-inflammation-and-cardiovascular-disease-from-university-of-london
Unigene In-Licenses Potential Therapies for Inflammation and Cardiovascular Disease From University of London
August 10, 2007
Unigene Laboratories, Inc. has acquired exclusive commercial rights to a combination therapy with potential value in the treatment of certain inflammatory diseases, and a novel peptide that may find application in the treatment of certain cardiovascular diseases.
Unigene